Teva Branded Pharmaceutical Products R&D, Inc.
Teva Branded Pharmaceutical Products R&D, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., is a leading player in the global pharmaceutical industry, headquartered in the United States. Founded in 1901, Teva has established itself as a pioneer in the development and manufacturing of generic and specialty medicines, with a strong focus on therapeutic areas such as central nervous system disorders, respiratory conditions, and oncology. With major operational regions across North America, Europe, and beyond, Teva is renowned for its extensive portfolio of high-quality medications. The company’s commitment to innovation is evident in its robust research and development efforts, which have led to numerous key milestones, including the launch of several groundbreaking treatments. Teva's unique approach to drug development and its market position as one of the largest generic drug manufacturers underscore its significant contributions to improving patient outcomes worldwide.
DitchCarbon Score
How does Teva Branded Pharmaceutical Products R&D, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Teva Branded Pharmaceutical Products R&D, Inc.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Teva Branded Pharmaceutical Products R&D, Inc.'s reported carbon emissions
Teva Branded Pharmaceutical Products R&D, Inc., headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Teva may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its initiatives. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Teva to establish clear climate commitments and reduction targets to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Teva Branded Pharmaceutical Products R&D, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
